Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries

CompletedOBSERVATIONAL
Enrollment

371

Participants

Timeline

Start Date

September 29, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

November 22, 2019

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Lutonix 014 Drug Coated Balloon PTA Catheter

Drug Coated Balloon PTA Catheter for Treatment of Below-the-Knee (BTK) Arteries

Trial Locations (26)

3354

King Faisal Hospital and Medical research Center, Riyadh

3600

Ziekenhuis Oost Limburg, Genk

4031

University Hospital Basel, Basel

8036

LKH-Univ. Klinikum Graz, Graz

8500

AZ Groeninghe, Kortrijk

9020

Klinikum Klagenfurt am Wörthersee, Klagenfurt

10126

A.O.U. Citta della Salute e della Scienza di Torino, Torino

20052

Policlinico di Monza, Monza

26504

Patras University Hospital, Pátrai

75015

Hôpital européen Georges-Pompidou, Paris

79189

Universitäts-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen

81675

Klinikum Rechts der Isar, Munich

83022

Klinikum Rosenheim, Rosenheim

Unknown

Medical University Vienna, Department of Angiology, Vienna

Medical University Vienna, Department of Radiodiagnostic, Vienna

Klinikum Hochsauerland, Arnsberg

Marienhospital Osnabrück, Osnabrück

MEDINOS Klinik Sonneberg, Sonneberg

Kreiskrankenhaus Viechtach, Viechtach

Attikon University Hospital, Athens

Clinica Montevergine, Mercogliano

University Hospital Zurich, Zurich

University Hospital of South Manchester, Manchester

04103

Universitaetsklinikum Leipzig, Leipzig

1169-1024

Hospital Santa Marta (C.H.Lisboa Central), Lisbon

08208

Corporación Sanitaria Parc Taulí, Sabadell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02554266 - Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries | Biotech Hunter | Biotech Hunter